Plasma cell leukaemia. Diagnostic problems in our experience with 11 cases

Plasma cell leukaemia (PCL) remains a rare and poorly understood variant of plasma cell disorders. Prior research has shown that PCL is often misdiagnosed due to overlapping features with other B-cell malignancies. Established knowledge includes the role of plasma cells in immune function and their malignant transformation in conditions like multiple myeloma. No prior work had resolved the full clinical and diagnostic spectrum of PCL. This gap motivated a closer examination of clinical and laboratory features. The uncertainty in diagnosis led to a need for better characterization of PCL. The lack of clear diagnostic criteria hindered accurate reporting of incidence. Researchers propose that TEM examination could improve detection rates. Understanding these patterns may help refine diagnostic approaches.

This study aimed to clarify the clinical and diagnostic features of plasma cell leukaemia (PCL) using a case series of 11 patients. The goal was to identify distinguishing characteristics that could aid in accurate diagnosis. The researchers sought to compare these findings with previously reported cases in the literature. They focused on four key aspects: clinical presentation, disease frequency, M component production, and diagnostic challenges. The motivation stemmed from the difficulty in diagnosing PCL due to overlapping features with other B-cell disorders. The authors propose that TEM could play a critical role in diagnosis. The study also aimed to assess treatment responses in PCL patients. These insights may help improve diagnostic accuracy and patient outcomes.

The authors collected clinical, haematological, immunological, and biochemical data from 11 PCL patients. They compared these findings with the largest published series of PCL cases. Transmission electron microscopy (TEM) was used to examine circulating plasma cells. The study focused on four specific aspects of the disease. The researchers evaluated the clinical picture at admission and disease frequency. They assessed M component production in relation to plasma cell maturity. Diagnostic challenges were analyzed using morphological and TEM findings. The authors propose that routine TEM examination could improve detection rates. This approach allowed for detailed comparison with prior literature.

The study found that PCL patients presented with severe anemia and prominent hepatosplenomegaly. Bone lesions were uncommon and, when present, were typically non-osteolytic. The response to treatment with alkylating agents and glucocorticoids was poor. TEM examination was necessary for accurate diagnosis in many cases. Morphological features of circulating plasma cells were often ambiguous. The frequency of PCL in this series was 11%, suggesting it is a more common variant than previously thought. M component production varied with plasma cell maturity and type. The authors propose that routine TEM could significantly improve diagnostic accuracy. These findings highlight the importance of TEM in PCL diagnosis.

The authors conclude that PCL is a distinct clinical entity with specific features such as severe anemia and poor treatment response. They propose that TEM is essential for accurate diagnosis due to ambiguous morphological features. The study suggests that PCL is more common than previously believed, with an incidence of 11% in their series. The authors emphasize the diagnostic challenges posed by overlapping features with other B-cell disorders. They suggest that routine TEM examination could improve detection rates. The findings support the need for updated diagnostic criteria for PCL. The authors propose that PCL should be considered in cases of immunocytic dyscrasias with atypical plasma cells. These insights may help improve clinical management and diagnostic accuracy.